| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/28/2011 | WO2010148177A3 Compounds, compositions, methods of synthesis, and methods of treatment |
| 04/28/2011 | WO2010144498A9 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate |
| 04/28/2011 | WO2010143825A3 Anti-arthritic agent using cyathula officinalis |
| 04/28/2011 | WO2010141666A3 Modulating endogenous beta-endorphin levels |
| 04/28/2011 | WO2010141592A3 Chemical fragment screening and assembly utilizing common chemistry for nmr probe introduction and fragment linkage |
| 04/28/2011 | WO2010140869A3 Complex, multilayer using the same, and device coated with the multilayer |
| 04/28/2011 | WO2010138955A3 Methods and compositions for treating neoplasia |
| 04/28/2011 | WO2010138868A3 Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting b2 adrenergic receptor agonists and associated methods and systems |
| 04/28/2011 | WO2010138770A3 Methods for administration and formulations for the treatment of regional adipose tissue |
| 04/28/2011 | WO2010138419A3 Materials and methods for treating viral infections |
| 04/28/2011 | WO2010135736A3 Application and uses of prg4 and therapeutic modulation thereof |
| 04/28/2011 | WO2010132873A3 Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase |
| 04/28/2011 | WO2010132821A3 Methods and compositions for treating degenerative and ischemic disorders |
| 04/28/2011 | WO2010125576A3 A process for isolation of lutein and zeaxanthin crystals from plant sources |
| 04/28/2011 | WO2010122583A3 Oral pharmaceutical compositions of acid labile substances |
| 04/28/2011 | WO2010119384A3 A medicinal cream made using mometasone furoate, and chitosan, and a process to make the same |
| 04/28/2011 | WO2010117873A3 Progesterone solutions for increased bioavailability |
| 04/28/2011 | WO2010089128A3 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| 04/28/2011 | WO2010086454A9 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases |
| 04/28/2011 | WO2010072183A3 Beer and beer-based beverages and method of modification of polyphenols and silicon content in these beverages |
| 04/28/2011 | WO2010038086A8 P38 map kinase inhibitors |
| 04/28/2011 | WO2009152340A3 Use of 2,3-substituted thiophenes for the treatment of lung inflammation |
| 04/28/2011 | WO2009037584A3 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease |
| 04/28/2011 | WO2009019616A3 Isoprekinamycin analogs and syntheses thereof |
| 04/28/2011 | WO2009004496A3 Bisanthrapyrazoles as anti-cancer agents |
| 04/28/2011 | WO2008017586A3 Special carbonyl-bis imino compounds for using as p2y11 receptor agonists in the treatment of immune diseases |
| 04/28/2011 | WO2006018221A9 Dihydropteridinone infusion solution having a long shelf life |
| 04/28/2011 | US20110098797 Drug eluting composite |
| 04/28/2011 | US20110098724 Antimicrobial Coatings with Preferred Microstructure for Medical Devices |
| 04/28/2011 | US20110098677 Functionalization of Micro- and Nano-Particles for Selective Attachment to Calcium Biomineral Surfaces |
| 04/28/2011 | US20110098640 Visual indication of rupture of drug reservoir |
| 04/28/2011 | US20110098631 Medical devices for treating urological and uterine conditions |
| 04/28/2011 | US20110098504 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/28/2011 | US20110098460 SiRNA Useful to Suppress expression of eIF-5A1 |
| 04/28/2011 | US20110098362 Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization |
| 04/28/2011 | US20110098361 Composition to enhance the bioavailability of curcumin |
| 04/28/2011 | US20110098360 Adamantane derivative for inhibiting toxicity of amyloid oligomer |
| 04/28/2011 | US20110098359 Compositions and Methods for Treatment of Glaucoma |
| 04/28/2011 | US20110098358 Human beta3 adrenergic receptor ligand, and food or pharmaceutical product containing the same |
| 04/28/2011 | US20110098357 Vaginal suppository comprising lactic acid |
| 04/28/2011 | US20110098356 Production and Purification of Esters of Polyunsaturated Fatty Acids |
| 04/28/2011 | US20110098355 Method of preparing a latanoprost ophthalmic solution and resulting solution |
| 04/28/2011 | US20110098354 Method of preparing a latanoprost ophthalmic solution and the resulting solution |
| 04/28/2011 | US20110098353 Compounds for Imaging and Therapy |
| 04/28/2011 | US20110098352 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| 04/28/2011 | US20110098351 Lactone compounds which can be used as antioxidant agents in pharmaceutical, cosmetic or food compositions and their method of preparation |
| 04/28/2011 | US20110098350 Substituted cyclohexylidene-ethylidene-octahydro-indene compounds |
| 04/28/2011 | US20110098349 Cathechins for the treatment of systemic aa amyloidosis |
| 04/28/2011 | US20110098348 Cannabis sativa plants rich in cannabichromene and its acid, extracts thereof and methods of obtaining extracts therefrom |
| 04/28/2011 | US20110098347 Phosphorous binder for treatment of kidney disease |
| 04/28/2011 | US20110098346 Nucleic acid molecule and method of targeting gene expression to gliomas |
| 04/28/2011 | US20110098345 Aptamers to Tissue Factor Pathway Inhibitor and Their Use as Bleeding Disorder Therapeutics |
| 04/28/2011 | US20110098344 Drug carrier |
| 04/28/2011 | US20110098343 Antisense Formulation |
| 04/28/2011 | US20110098342 Methods of detecting long range chromosomal interactions |
| 04/28/2011 | US20110098341 Use of id4 for diagnosis and treatment of cancer |
| 04/28/2011 | US20110098340 Antisense modulation of bcl2-associated x protein expression |
| 04/28/2011 | US20110098339 C2orf18 as target gene for cancer therapy and diagnosis |
| 04/28/2011 | US20110098338 RNA Interference for the Treatment of Heart Failure |
| 04/28/2011 | US20110098337 Inhibitors of RTP801 and their use in disease treatment |
| 04/28/2011 | US20110098336 Pyrrolidin-2-one derivatives as androgen receptor modulator |
| 04/28/2011 | US20110098335 Novel compounds |
| 04/28/2011 | US20110098334 Novel crystalline form of calcium zofenopril |
| 04/28/2011 | US20110098333 Methods for treating or preventing brain infections |
| 04/28/2011 | US20110098330 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 04/28/2011 | US20110098329 Catalyzed carbonylation in the synthesis of angiotensin ii antagonists |
| 04/28/2011 | US20110098328 Heterocyclic derivatives as modulators of ion channels |
| 04/28/2011 | US20110098327 Hepatitis C Virus Inhibitors |
| 04/28/2011 | US20110098326 2-fluorothiazole derivatives useful as imaging agents; methods of synthesis, and methods of use |
| 04/28/2011 | US20110098325 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 04/28/2011 | US20110098324 Prolyl hydroxylase inhibitors |
| 04/28/2011 | US20110098322 Preparation of novel 1,3-substituted ureas as inhibitors of soluble epoxide hydrolase |
| 04/28/2011 | US20110098321 Salts of methyl 2-((r)-(3-chlorophenyl)((r)-1-((s)-2-(methylamino)-3-((r)-tetrahydro-2h-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate |
| 04/28/2011 | US20110098320 Lactam Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 |
| 04/28/2011 | US20110098319 Fatty acid derivatives for oral administration endowed with high palatability |
| 04/28/2011 | US20110098318 Farnesyl protein transferase inhibitors for treating breast cancer |
| 04/28/2011 | US20110098317 Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer |
| 04/28/2011 | US20110098316 Chromane derivatives as trpv3 modulators |
| 04/28/2011 | US20110098315 Pharmaceutical compositions of rosuvastatin calcium |
| 04/28/2011 | US20110098314 Statins for the treatment of ocular hypertension and glaucoma |
| 04/28/2011 | US20110098313 Positive allosteric modulators (pam) |
| 04/28/2011 | US20110098312 Methods for preventing the development of retinopathy by the oral administration of nnr ligands |
| 04/28/2011 | US20110098311 Compositions for treatment of cystic fibrosis and other chronic diseases |
| 04/28/2011 | US20110098310 Novel compounds, use and preparation thereof |
| 04/28/2011 | US20110098309 Methods of inhibiting the formation of amyloid-beta diffusable ligands using acylhydrazide compounds |
| 04/28/2011 | US20110098308 Azaindazole compounds and methods of use |
| 04/28/2011 | US20110098307 Crystalline of eszopiclone, its composition, preparation and uses thereof |
| 04/28/2011 | US20110098306 Uses of tetrahydrobiopterin, sepiapterin and derivatives thereof |
| 04/28/2011 | US20110098305 Arylsulfonamide compounds, compositions and methods of use |
| 04/28/2011 | US20110098304 Small molecule inhibitors of PARP activity |
| 04/28/2011 | US20110098303 Method of promoting nail growth using thyromimetic compounds |
| 04/28/2011 | US20110098302 Cyclic diaryl ether compounds as antagonists of prostaglandin d2 receptors |
| 04/28/2011 | US20110098301 Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders |
| 04/28/2011 | US20110098300 Compounds Comprising A Cyclobutoxy Group |
| 04/28/2011 | US20110098299 Spirolactam derivatives and uses of same |
| 04/28/2011 | US20110098298 New Pyridin-3-Amine Derivatives |
| 04/28/2011 | US20110098297 Fused ring compounds and use thereof |
| 04/28/2011 | US20110098296 Thiazole And Oxazole Kinase Inhibitors |